1.01
price up icon0.50%   0.005
after-market Handel nachbörslich: 1.02 0.01 +0.99%
loading

Finanzdaten der Adial Pharmaceuticals Inc-Aktie (ADIL)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
3.43%
1.845
1.7838 1.3579 0.2227 2.9207
Operating Income/Loss
3.43%
-1.845
-1.7838 -1.3579 -1.4774 -2.9207
Nonoperating Income/Loss
3,741%
-4.6315
-0.1206 0.0102 -0.0325 0.0149
Income/Loss Before Equity Method Investments
-6.2867
- - - -
Income/Loss From Equity Method Investments
-0.1899
- - - -
Income/Loss From Continuing Operations Before Tax
240.08%
-6.4766
-1.9044 -1.3477 -1.5099 -2.9058
Income/Loss From Continuing Operations After Tax
240.08%
-6.4766
-1.9044 -1.3477 -1.5099 -2.9058
Net Income/Loss
237.26%
-6.4766
-1.9203 -1.385 1.0878 -2.9058
Preferred Stock Dividends And Other Adjustments
-
- - 0.868 -
Attributable To Noncontrolling Interest
-
- - - -
Diluted Average Shares
873.82%
2.9539
0.3033 1.1785 1.1314 26.46
Basic Earnings Per Share
195.95%
-2.19
-0.74 -1.18 0.96 -0.11
Diluted Earnings Per Share
195.95%
-2.19
-0.74 -1.18 0.96 -0.11
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - 0.868 -
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):